Jorge Cortes, MD, is the Director of the Georgia Cancer Center, Augusta University, Augusta, GA. He was previously in the Department of Leukemia at the MD Anderson Cancer Center (MDACC) in Houston, TX, where he had roles including Deputy Department Chair and Professor of Medicine.
Dr Cortes received his medical degree in 1986 from the Universidad Nacional Autonoma de Mexico in Mexico City, and completed his fellowship in Houston. His clinical interests include acute and chronic leukemias, particularly myeloid leukemias, myelodysplastic syndromes, and myeloproliferative neoplasms, and his research focuses on new drug development. Dr Cortes has worked on the development and approval of new leukemia drugs, such as bosutinib, ponatinib, CPX-351, quizartinib and crenolanib.
Dr Jorge Cortes has received various awards for his contributions in the field including the Annual Celgene Young Investigator Achievement Award for Clinical Research in Hematology in 2005, the Dr John J. Kenny Award from The Leukemia & Lymphoma Society in 2006, and the Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research from MDACC in 2007. He has authored nearly 1,000 manuscripts in peer-reviewed journals and is the principal investigator or co-principal investigator of many research studies.
He is an active user of Twitter, @GCC Cortes, where he shares exciting updates on the latest work in his field.